Alex Lechtman, MD
Plastic Surgery · Visalia, CANPI 1013913698
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,003 of the $11,941 with a category attached, or 83.8%. AbbVie accounts for 84.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $5,295 and has fallen 96.3% since, to $196 in 2025.
Across 39 payments — averaging $306.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- Medical Device Business Services, Inc.$969
- Mentor Worldwide LLC$420
- Merz North America, Inc.$225
- Sanofi$134
- TELA Bio, Inc.$108
- plus $59 from 4 others
Across 17 payments — averaging $917.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mentor Worldwide LLC$9K
- Medical Device Business Services, Inc.$6K
What the payments were for
- Speaking & faculty fees$10,00384%
- Travel & lodging$7486%
- Food & beverage$9758%
- Education$2152%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $10,026 |
| Medical Device Business Services, Inc. | 6 | $969 |
| Mentor Worldwide LLC | 15 | $420 |
| Merz North America, Inc. | 3 | $225 |
| Sanofi | 5 | $134 |
| TELA Bio, Inc. | 1 | $108 |
| Lilly USA, LLC | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Incyte Corporation | 1 | $15 |
| Abbott | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,941 in reported general payments places this provider in the 85th percentile of 780 plastic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $290 |
| Cephalexin | 14 | $85 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Visalia
- Rahm NazeraliPalo Alto$1.5M
- Vipul DevBakersfield$1.1M
- Arash MomeniPalo Alto$836K
- Anne PeledSan Francisco$570K
- Salvatore PacellaSan Diego$517K
- Hani SbitanySan Francisco$510K
- John ApostolidesSan Diego$460K
- Garrett WirthNewport Beach$362K
- Michael BainNewport Beach$341K
- Joshua KormanMountain View$335K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.